Valeritas Holdings, Inc. (NASDAQ:VLRX) reached a new 52-week low during trading on Tuesday . The stock traded as low as $2.05 and last traded at $2.05, with a volume of 7,586 shares trading hands. The stock had previously closed at $2.27.

Several equities research analysts recently issued reports on the stock. Wedbush assumed coverage on shares of Valeritas Holdings in a report on Monday, July 10th. They issued an “outperform” rating and a $12.00 target price for the company. ValuEngine lowered shares of Valeritas Holdings from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 19th.

The stock has a 50 day moving average of $3.06 and a 200-day moving average of $4.95. The stock’s market capitalization is $14.55 million.

Valeritas Holdings (NASDAQ:VLRX) last posted its quarterly earnings data on Friday, August 11th. The company reported ($1.83) EPS for the quarter, beating the Zacks’ consensus estimate of ($1.87) by $0.04. The business had revenue of $4.79 million during the quarter, compared to analysts’ expectations of $5.11 million. On average, equities research analysts predict that Valeritas Holdings, Inc. will post ($8.60) earnings per share for the current fiscal year.

An institutional investor recently bought a new position in Valeritas Holdings stock. C WorldWide Group Holding A S purchased a new position in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 233,952 shares of the company’s stock, valued at approximately $1,603,000. C WorldWide Group Holding A S owned approximately 3.42% of Valeritas Holdings as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 6.01% of the company’s stock.

WARNING: This article was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this article can be accessed at

About Valeritas Holdings

Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.

Receive News & Stock Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related stocks with our FREE daily email newsletter.